Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Life Sciences Industry Hampered by Slow Digital Progress
June 29, 2015.
A new study by assessing the "overall digital maturity" of life sciences companies reveals that they are "not maturing fast enough". Across Health's Multichannel Maturometer suggests that a lack of a strong vision and strategy is to blame; only one in four respondents said they felt their company had a digital strategy. Only 13% of the survey's respondents were satisfied to very satisfied with their digital initiatives, with 42% not satisfied and 40% not sure. Dissatisfaction has thus dropped to 2010-2011 levels. According to Across Health, the top bottlenecks include regulatory issues, no clear digital strategy and not enough internal knowledge. For more information on the study results, click here.
Recent Videos
Related Content
